Apotheca Biosciences, Inc. (OTCPK:CBDC) entered into a definitive agreement to acquire 51% stake in Hemp Sciences Corp from Nuvus Gro Corp. (OTCPK:NUVG) for $4 million on June 3, 2019. Apotheca will issue 60 million shares a consideration. The purchase agreement will come with customary leak out and lock out agreement for the term of 12 months. Apotheca expects the acquisition to complete before the end of second quarter 2019 or July 31, 2019. Apotheca Biosciences, Inc. (OTCPK:CBDC) cancelled the acquisition of 51% stake in Hemp Sciences Corp from Nuvus Gro Corp. (OTCPK:NUVG) on June 3, 2020.